Filing Details
- Accession Number:
- 0001062993-25-010245
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-05-23 16:14:42
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-23
- Accepted Time:
- 2025-05-23 16:14:42
- Original Submission Date:
- 2025-05-22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1799011 | Lucid Diagnostics Inc. | LUCD | Surgical & Medical Instruments & Apparatus (3841) | 825488042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1817012 | Dennis Matheis | 360 Madison Avenue, 25Th Floor New York NY 10017 | Yes | No | No | No |
Transaction Summary
Purchased: | 350,000 shares | Avg. Price: $1.31 | Total Value: $457,606.58 |
Number of Shares After Transactions: | 565,443 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-20 | 187,098 | $1.30 | 402,541 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-05-21 | 129,684 | $1.32 | 532,225 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-05-22 | 33,218 | $1.32 | 565,443 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.315 to $1.32, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.305 to $1.32, inclusive.
- Includes 52,718 shares of Lucid common stock distributed on a pro rata basis to the reporting person by a limited partnership of which the reporting person is a limited partner.